Abstract
The non-invasive diagnosis of coronary artery disease in hypertensives with chest pain is an important clinical concern because all exercise-dependent tests display limited feasibility and diagnostic accuracy; by contrast, dipyridamole echocardiography testing has been shown to have a similar feasibility and accuracy in hypertensive and normotensive subjects. The aim of this study was to evaluate the diagnostic capability of technetium-99m sestamibi tomography based on dipyridamole echocardiography testing in hypertensives with chest pain, and to compare the scintigraphic results with those of coronary angiography, exercise electrocardiography and dipyridamole echocardiography. Forty subjects with mild to moderate hypertension, chest pain and no previous myocardial infarction were submitted to99mTc-sestamibi tomography (at rest and after high-dose dipyridamole echocardiography) and to exercise electrocardiography testing. At coronary angiography 22 patients (group A) had significant epicardial coronary artery disease (≥70% stenosis of at least one major vessel) and 18 normal main coronary vessels (group B). Dipyridamole99mTc-sestamibi imaging was positive in 21/22 patients of group A and in 5/18 of group B. Dipyridamole echocardiography was positive in 18/22 patients of group A and in 5/18 of group B. Exercise electrocardiography was positive in 15/22 patients of group A and in 11/18 of group B. Four out of five subjects in group B with positive results in all the tests showed a slow run-off of angiographic contrast medium, probably due to small-vessel disease. Significant epicardial coronary artery disease in hypertensives with chest pain is unlikely when dipyridamole99mTc-sestamibi tomography is negative. When scintigraphy is positive, either epicardial coronary artery disease or a small-vessel disease condition is possible. The association of scintigraphy with dipyridamole echocardiography testing allows the assessment of contractile function and myocardial perfusion by a single pharmacological stress.
Similar content being viewed by others
References
Prisant LM, Frank MJ, Carr AA, von Dholen TW, Abdulla AM. How can we diagnose heart disease in hypertensive patients?Hypertension 1987; 10: 467–472.
Frohlic ED. Coexistence of hypertensive and coronary arterial disease.Hypertension 1987; 10: 473–475.
Priant LM, Watkins LO, Carr AA. Exercise stress testing.South Med J 1984; 77: 1551–1556.
Wasserman AG, Katz RJ, Varghese PS, et al. Exercise radionuclide ventriculographie response in hypertensive patients with chest pain.N Engl J Med 1984; 311: 1276–1280.
Schulman DS, Francis CK, Black HR, Wackers FJT. Thallium-201 stress imaging in hypertensive patients.Hypertension 1987;10:16–21.
Beller GA. Pharmacologic stress imaging.DAMA 1991; 265: 633–638.
Iskandrian AS, Verani MS, Heo J. Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.J Nucl Cardiol 1994;1:94–111.
Picano E, Lucarini AR, Lattanzi F, et al. Dipyridamole echocardiography in essential hypertensive patients with chest pain.Hypertension 1988; 12: 238–243.
Lucarini AL, Picano E, Lattanzi F, et al. Dipyridamole echocardiography stress testing in hypertensive patients: targets and tools.Circulation 1991; 83 Suppl III: III68-III73.
Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method.Circulation 1977; 52:613–618.
Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris.J Am Coll Cardiol 1986; 8: 848–854.
Kiat H, Maddhai J, Roy LT, Friedman J, Resser K, Berman DS. Comparison of technetium 99m methoxyisobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods.Am Heart J 1989: 117: 1–11.
Cuocolo A, Soricelli A, Pace L, et al. Adenosine technetium99m-methoxy isobutyl isonitrile myocardial tomography in patients with coronary artery disease: comparison with exercise.J Nucl Med 1994; 35: 1110–1115.
Beller GA. Dipyridamole thallium-201 scintigraphy: an excellent alternative to exercise scintigraphy.J Am Coll Cardiol 1989; 14: 1642–1644.
Tartagni F, Dondi M, Limonetti P, et al. Dipyridamole technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels: comparison with thallium-201 stress-rest study.J Nucl Med 1991: 32: 369–376.
Schillaci O, Scopinaro F, Moroni C, et al. Tc-99m MIBI SPECT after dipyrididamole echocardiography test in the diagnosis and localization of CAD [abstract].Eur J Nucl Med 1996;23:1158.
Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery diseases: analysis of 461 patients.J Am Coll Cardiol 1989; 14: 1477–1486.
Rossen JD, Simonetti I, Marcus ML, Winniford MD. Coronary dilatation with standard dose dipyridamole and dipyridamole combined with handgrip.Circulation 1989; 79:566–572.
Iskandrian AS, Heo J. Pharmacologic stress testing. In: Zaret BL, Beller GA, eds.Nuclear cardiology: state of the art and future directions. St. Louis: Mosby-Year Book; 1992: 170–180.
Parodi O, Marcassa C, Casucci R, et al. Accuracy and safety of technetium-99m hexakis-2-methoxy-isobutyl isonitrile (sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectors: a multicenter study.J Am Coll Cardiol 1991; 18: 1439–1444.
Lette J, Tatum JL, Fraser S, et al. Safety of dipyridamole testing in 73,806 patients: The Multicenter Dipyridamole Safety Study.J Nucl Cardiol 1995; 2: 3–17.
Lalonde D, Taillefer R, Lambert R, et al. Thallium-201-dipyridamole imaging: comparison between a standard dose and a high dose of dipyridamole in the detection of coronary artery disease.J Nucl Med 1994; 35: 1245–1253.
Nguyen T, Heo J, Ogilby JD, Iskandrian AS. Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography.J Am Coll Cardiol 1990; 16: 1375–1383.
Pozzoli MMA, Fioretti PM, Salustri A, Reijs AEM, Roelandt JRTC. Exercise echocardiography and technetium-99m MIBI single-photon emission tomography in the detection of coronary artery disease.Am J Cardiol 1991; 67:350–355.
Fung AJ, Gallagher KP, Buda AJ. The physiologic basic of dobutamine as compared with dipyridamole stress intervention in the assessment of critical coronary stensosis.Circulation 1987; 76:943–951
Margonato A, Chierchia S, Cianfrone D, et al. Limitations of dipyridamole-echocardiography in effort angina pectors.Am J Cardiol 1987; 59:225–230.
Picano E, Lattanzi F, Orlandini A, Marini C, L'Abbate A. Stress echocardiography and the human factor: the importance of being expert.J Am Coll Cardiol 1991; 17:666–669.
Mosseri M, Yarom R, Gotsman MS, Hasin Y, Histologic evidence for small-vessel coronary artery disease in patients with angina pectors and patent large coronary arteries.Circulation 1986;74:964–972.
Brush JE Jr, Cannon RO III, Schenke WH, et al. Angina due to microvascular disease in hypertensive patients without left ventricular hypertrophy.N Engl J Med 1988; 319:1302–1307.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schillaci, O., Moroni, C., Scopinaro, F. et al. Technetium-99m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain. Eur J Nucl Med 24, 774–778 (1997). https://doi.org/10.1007/BF00879666
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00879666